Forbion Capital Fund IV Cooperatief U.A. 13D/13G Filings for Achilles Therapeutics plc (ACHL)

Forbion Capital Fund IV Cooperatief U.A. 13D and 13G filings for Achilles Therapeutics plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-11
09:20 am
Purchase
2021-12-3113GAchilles Therapeutics plc
ACHL
Forbion Capital Fund IV Cooperatief U.A.2,390,050
5.890%
2,390,050increase
(New Position)
Filing